Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients

This work’s objective was to evaluate the safety of isavuconazole (ISA) as a treatment or prophylaxis for invasive fungal infections (IFIs) in immunocompromised children. IFI was reported as proven or probable according to international definitions. Therapeutic drug monitoring was performed using ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Zimmermann, Philippe, Brethon, Benoit, Roupret-Serzec, Julie, Caseris, Marion, Goldwirt, Lauriane, Baruchel, André, de Tersant, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949553/
https://www.ncbi.nlm.nih.gov/pubmed/35337172
http://dx.doi.org/10.3390/ph15030375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949553/
https://www.ncbi.nlm.nih.gov/pubmed/35337172
http://dx.doi.org/10.3390/ph15030375

Ejemplares similares